This company seems to have been delisted
Reason: Acquired by Lundbeck
Last recorded trade on: January 31, 2025
Source: https://news.cision.com/h--lundbeck-a-s/r/lundbeck-completes-acquisition-of-longboard,c4074636
Reason: Acquired by Lundbeck
Last recorded trade on: January 31, 2025
Source: https://news.cision.com/h--lundbeck-a-s/r/lundbeck-completes-acquisition-of-longboard,c4074636
Longboard Pharmaceuticals
LBPH
C$82.59
Share price
0.00%
Change (1 day)
183.28%
Change (1 year)
Categories
Longboard Pharmaceuticals (LBPH) Fails to deliver data
Key failure to deliver metrics for Longboard Pharmaceuticals:
- Last SEC data release: 2025-06-30
- Last 15 days FTD volume: N/A
- Last 3 months FTD volume: N/A
- Last year FTD volume: N/A
A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.
Failures to deliver for Longboard Pharmaceuticals (LBPH) - 3 months history
Number of shares, 3 months chart
Biweekly Failures to deliver volume for Longboard Pharmaceuticals (LBPH) - since 2021
Volume in USD (price x number of shares), data since 2021Longboard Pharmaceuticals (LBPH) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | C$35.23 M | 3807.42% |
| 2023 | C$0.9 M | 687.51% |
| 2022 | C$0.11 M | -99.37% |
| 2021 | C$18.24 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3 months) | FTD volume (1 year) | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | C$2.35 M | C$10.02 M | 🇺🇸 USA |